Immunocompromised
Also known as: Patient immunosuppressed / Immunocompromised Host / Immunodeficiency syndromes / Immunodeficiency, unspecified / Immunodeficiency NOS / Immunodeficiency / Unspecified immunity deficiency / Immunologic Deficiency Syndromes
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00787 | Acyclovir | A guanosine analog used to treat herpes simplex, varicella zoster, herpes zoster. |
| DB15718 | Bamlanivimab | A neutralizing human IgG1κ monoclonal antibody against the SARS-CoV-2 spike (S) protein for use in patients aged 12 and over at high risk of developing severe COVID-19. |
| DB15897 | Etesevimab | Etesevimab in combination with bamlanivimab is used to treat mild to moderate coronavirus disease 2019 (COVID-19) in adults and pediatric patients, including neonates, with positive results of direct SARS-CoV-2 viral... |
| DB00529 | Foscarnet | An antiviral used to treat CMV, HIV, and HSV infections. |
| DB01004 | Ganciclovir | A DNA polymerase inhibitor used to treat cytomegalovirus and herpetic keratitis of the eye. |
| DB01263 | Posaconazole | A triazole antifungal drug that is used to treat invasive infections by Candida species and Aspergillus species in severely immunocompromised patients. |
| DB01015 | Sulfamethoxazole | An oral sulfonamide antibiotic, given in combination with trimethoprim, used to treat a variety of infections of the urinary tract, respiratory system, and gastrointestinal tract. |
| DB00864 | Tacrolimus | A calcineurin inhibitor used to prevent organ transplant rejection and to treat moderate to severe atopic dermatitis. |
| DB00440 | Trimethoprim | An antifolate antibiotic often used in combination with sulfamethoxazole to treat a number of infections, including those of the urinary tract, respiratory tract, and gastrointestinal tract. |
| DB01157 | Trimetrexate | A folate antagonist used for the treatment of moderate-to-severe Pneumocystis carinii pneumonia (PCP) in immunocompromised patients as an alternative therapy in combination with leucovorin. |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB01141 | Micafungin | 1 | Terminated | 1 |
| DB14455 | Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (formaldehyde inactivated) | 2 | Completed | 1 |
| DB10792 | Influenza A virus A/Switzerland/9715293/2013 NIB-88 (H3N2) antigen (formaldehyde inactivated) | 2 | Completed | 1 |
| DB14456 | Influenza B virus B/Brisbane/9/2014 antigen (formaldehyde inactivated) | 2 | Completed | 1 |
| DB16691 | Nirmatrelvir | 2 | Withdrawn | 1 |
| DB00503 | Ritonavir | 2 | Withdrawn | 1 |
| DB15691 | Anti-SARS-CoV-2 REGN-COV2 | 3 | Terminated | 1 |
| DB15941 | Casirivimab | 3 | Terminated | 1 |
| DB15313 | DAS-181 | 3 | Recruiting | 1 |
| DB15940 | Imdevimab | 3 | Terminated | 1 |
| DB15696 | Tozinameran | Not Available | Completed | 1 |